Karlin Daniel Insider Trades

Insider Trading History

Track insider trading activity for Karlin Daniel. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $30.1M 803,699 shares
Last Trade
Sep 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.05M 200,000 shares
$40.25
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $22.6M 603,282 shares
Last Trade
Aug 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.28M 100,000 shares
$42.79
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $18.8M 503,282 shares
Last Trade
Jun 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$452k 10,035 shares
$45.03
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $19.2M 513,317 shares
Last Trade
Jun 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.45M 100,000 shares
$24.48
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $15.5M 413,317 shares
Last Trade
Mar 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $21.5M 575,025 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $15.9M 425,025 shares
Last Trade
Dec 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $16.1M 430,625 shares
Last Trade
Sep 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$37.40
Mind Medicine
Mind Medicine MNMD
Chief Medical Officer
Holding Value $8.91M 430,625 shares
Last Trade
Sep 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$75.3k 7,704 shares
$9.77
$20.69
Mind Medicine
Mind Medicine MNMD
Chief Medical Officer
Holding Value $9.07M 438,329 shares
Last Trade
Jun 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$53.4k 7,848 shares
$6.80
$20.69
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $16.4M 438,329 shares
Last Trade
Jun 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$37.40
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $16.7M 446,177 shares
Last Trade
Mar 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$37.40
Mind Medicine
Mind Medicine MNMD
Chief Medical Officer
Holding Value $9.23M 446,177 shares
Last Trade
Mar 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$46.1k 6,836 shares
$6.74
$20.69
Definium Therapeutics
Definium Therapeutics DFTX
Chief Medical Officer
Holding Value $16.9M 453,013 shares
Last Trade
Mar 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$37.40
Mind Medicine
Mind Medicine MNMD
Chief Medical Officer
Holding Value $9.37M 453,013 shares
Last Trade
Mar 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$742k 115,000 shares
$6.45
$20.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up